Free Trial

Brown Advisory Inc. Grows Stock Position in Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health logo with Medical background

Brown Advisory Inc. lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 9.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 169,633 shares of the company's stock after purchasing an additional 14,087 shares during the quarter. Brown Advisory Inc. owned 0.07% of Cardinal Health worth $20,062,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Balyasny Asset Management L.P. bought a new stake in Cardinal Health in the 4th quarter worth approximately $39,910,000. Aptus Capital Advisors LLC lifted its holdings in shares of Cardinal Health by 97.8% in the 4th quarter. Aptus Capital Advisors LLC now owns 3,796 shares of the company's stock worth $449,000 after acquiring an additional 1,877 shares during the last quarter. AXA S.A. boosted its stake in shares of Cardinal Health by 47.8% in the 4th quarter. AXA S.A. now owns 535,739 shares of the company's stock valued at $63,362,000 after purchasing an additional 173,250 shares in the last quarter. Wahed Invest LLC grew its holdings in shares of Cardinal Health by 6.4% during the 4th quarter. Wahed Invest LLC now owns 6,292 shares of the company's stock valued at $741,000 after purchasing an additional 378 shares during the last quarter. Finally, Itau Unibanco Holding S.A. purchased a new position in Cardinal Health in the 4th quarter worth $36,000. 87.17% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Mizuho lifted their price objective on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a report on Monday, March 31st. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. StockNews.com upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. JPMorgan Chase & Co. boosted their price objective on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Finally, Morgan Stanley increased their target price on shares of Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $146.43.

View Our Latest Stock Analysis on Cardinal Health

Cardinal Health Price Performance

NYSE:CAH traded up $1.09 during mid-day trading on Friday, hitting $148.36. 3,241,366 shares of the company's stock were exchanged, compared to its average volume of 2,212,024. The company has a market cap of $35.41 billion, a PE ratio of 27.68, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $154.07. The business has a fifty day moving average price of $134.65 and a 200 day moving average price of $126.40.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm's quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.08 EPS. On average, equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a dividend yield of 1.38%. Cardinal Health's dividend payout ratio (DPR) is 31.51%.

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

See Also

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines